Cargando…

Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls

BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fielding, S., Macleod, A.D., Counsell, C.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110002/
https://www.ncbi.nlm.nih.gov/pubmed/27553511
http://dx.doi.org/10.1016/j.parkreldis.2016.08.010
_version_ 1782467640736874496
author Fielding, S.
Macleod, A.D.
Counsell, C.E.
author_facet Fielding, S.
Macleod, A.D.
Counsell, C.E.
author_sort Fielding, S.
collection PubMed
description BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism and age-sex matched controls. Participants have annual follow-up from diagnosis until death with review of primary/secondary care records and linkage to the UK death register. Data are collected on survival, disability (dependency on others for activities of daily living) and institutionalization. Research criteria are used to guide the clinical diagnosis, which is updated annually. We compared all-cause mortality, disability and institutionalization in patients (subdivided by diagnosis) and controls, adjusted for important confounders. RESULTS: 323 incident parkinsonian patients (199 Parkinson's disease, 124 atypical parkinsonism, mean age at diagnosis 75yrs) and 262 controls (mean age 75yrs) had 1349 and 1334 person-years follow-up respectively (maximum follow-up 10 years). All outcomes were worse in parkinsonian patients than controls, especially in atypical parkinsonism (adjusted mortality hazards ratios Parkinson's disease 2.49, 95%CI 1.72–3.58, atypical parkinsonism, 6.85, 95%CI 4.78–9.81). Median survival times for Parkinson's disease and atypical parkinsonism were 7.8 and 2.7 years respectively but were very age-dependent. At three years the rates of death or dependency were controls 21%, Parkinson's disease 46%, atypical parkinsonism 96% whilst overall institutionalization rates were 5%, 15% and 55% respectively. CONCLUSION: The prognosis of Parkinson's disease and atypical parkinsonism in this unselected incident cohort was significantly worse than previously reported. This has important implications for patient management.
format Online
Article
Text
id pubmed-5110002
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-51100022016-11-21 Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls Fielding, S. Macleod, A.D. Counsell, C.E. Parkinsonism Relat Disord Article BACKGROUND: The best data on prognosis comes from population-based incident cohorts but few such cohorts exist for Parkinson's disease and atypical parkinsonism. METHODS: The PINE study is a prospective follow-up study of an incident cohort of people with degenerative or vascular parkinsonism and age-sex matched controls. Participants have annual follow-up from diagnosis until death with review of primary/secondary care records and linkage to the UK death register. Data are collected on survival, disability (dependency on others for activities of daily living) and institutionalization. Research criteria are used to guide the clinical diagnosis, which is updated annually. We compared all-cause mortality, disability and institutionalization in patients (subdivided by diagnosis) and controls, adjusted for important confounders. RESULTS: 323 incident parkinsonian patients (199 Parkinson's disease, 124 atypical parkinsonism, mean age at diagnosis 75yrs) and 262 controls (mean age 75yrs) had 1349 and 1334 person-years follow-up respectively (maximum follow-up 10 years). All outcomes were worse in parkinsonian patients than controls, especially in atypical parkinsonism (adjusted mortality hazards ratios Parkinson's disease 2.49, 95%CI 1.72–3.58, atypical parkinsonism, 6.85, 95%CI 4.78–9.81). Median survival times for Parkinson's disease and atypical parkinsonism were 7.8 and 2.7 years respectively but were very age-dependent. At three years the rates of death or dependency were controls 21%, Parkinson's disease 46%, atypical parkinsonism 96% whilst overall institutionalization rates were 5%, 15% and 55% respectively. CONCLUSION: The prognosis of Parkinson's disease and atypical parkinsonism in this unselected incident cohort was significantly worse than previously reported. This has important implications for patient management. Elsevier Science 2016-11 /pmc/articles/PMC5110002/ /pubmed/27553511 http://dx.doi.org/10.1016/j.parkreldis.2016.08.010 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Fielding, S.
Macleod, A.D.
Counsell, C.E.
Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title_full Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title_fullStr Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title_full_unstemmed Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title_short Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
title_sort medium-term prognosis of an incident cohort of parkinsonian patients compared to controls
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110002/
https://www.ncbi.nlm.nih.gov/pubmed/27553511
http://dx.doi.org/10.1016/j.parkreldis.2016.08.010
work_keys_str_mv AT fieldings mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols
AT macleodad mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols
AT counsellce mediumtermprognosisofanincidentcohortofparkinsonianpatientscomparedtocontrols